Invenomic Capital Management’s Teladoc Health TDOC Stock Holding History

Invenomic Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,372,977	Closed	-$10.6M	–	170
2025 Q3	$10.6M	Sell	1,372,977 -73,385	-5%	-$573K	0.51%	71
2025 Q2	$12.6M	Buy	1,446,362 +119,234	+9%	+$864K	0.72%	50
2025 Q1	$10.6M	Buy	1,327,128 +353,478	+36%	+$3.58M	0.53%	67
2024 Q4	$8.85M	Sell	973,650 -500,687	-34%	-$4.83M	0.42%	80
2024 Q3	$13.5M	Buy	1,474,337 +896,552	+155%	+$7.42M	0.74%	46
2024 Q2	$5.65M	Buy	577,785 +391,067	+209%	+$4.77M	0.28%	96
2024 Q1	$2.82M	Buy	+186,718	New	+$3.39M	0.15%	121

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invenomic Capital Management's TDOC Position: Q4 2025 in Review

Invenomic Capital Management sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 1,372,977 shares — an estimated $10.6M sold.

Invenomic Capital Management first reported a position in TDOC in Q1 2024 and held it in 7 quarters. The position peaked at $13.5M in Q3 2024. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

Invenomic Capital Management reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
Invenomic Capital Management sold 1,372,977 Teladoc Health shares in Q4 2025, an estimated $10.6M.
Invenomic Capital Management first reported a position in Teladoc Health in Q1 2024 and held it in 7 quarters.
Invenomic Capital Management's Teladoc Health position peaked at $13.5M in Q3 2024.
344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Invenomic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.